The Neuromuscular Challenge in the Intensive Care Unit
Managing patients with acute neuromuscular disorders (NMD) in the intensive care unit (ICU) represents one of the most complex challenges in respiratory medicine. Unlike patients with primary pulmonary diseases, individuals with Guillain-Barré syndrome (GBS) or myasthenia gravis (MG) often possess healthy lung parenchyma but suffer from a failure of the ‘respiratory pump.’ This failure, driven by peripheral nerve demyelination or neuromuscular junction blockade, leads to a unique and often unpredictable weaning process. Until recently, large-scale data detailing the specific characteristics of ventilator weaning in these populations were limited, leaving clinicians to rely on small cohorts or institutional protocols.
A new nationwide multicenter study published in Intensive Care Medicine (2025) provides much-needed clarity. By analyzing nearly 900 patients over a ten-year period, researchers have mapped the distinct trajectories of GBS and MG patients, highlighting significant disparities in weaning duration, tracheostomy rates, and the persistent threat of extubation failure.
